Augmedix announced that Tomer Levy joined the company in January 2024 in the newly-created Senior Vice President, SVP, of Engineering role. Prior to joining Augmedix, Levy most recently served as Senior Vice President of Research and Development at Change Healthcare.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on AUGX:
- Augmedix Names Tomer Levy as New Senior Vice President of Engineering
- Augmedix Announces Participation in Maxim Group Virtual Healthcare IT Investor Conference
- Augmedix sees Q4 revenue $12.5M, consensus $12.4M
- Augmedix Exits Calendar 2023 with Expected $51 Million in Annual Recurring Revenue
- Augmedix initiated with neutral view at Evercore ISI, here’s why